nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—NME1—peripheral nervous system neoplasm	0.58	1	CbGaD
Tenofovir—ABCC10—Vincristine—peripheral nervous system neoplasm	0.07	0.245	CbGbCtD
Tenofovir—ABCC10—Etoposide—peripheral nervous system neoplasm	0.0642	0.225	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.0438	0.153	CbGbCtD
Tenofovir—ABCC2—Vincristine—peripheral nervous system neoplasm	0.02	0.07	CbGbCtD
Tenofovir—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0187	0.0653	CbGbCtD
Tenofovir—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0183	0.0642	CbGbCtD
Tenofovir—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0175	0.0612	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.014	0.0489	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0125	0.0438	CbGbCtD
Tenofovir—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00684	0.0239	CbGbCtD
Tenofovir—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.0063	0.16	CbGpPWpGaD
Tenofovir—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00437	0.111	CbGpPWpGaD
Tenofovir—Adefovir Dipivoxil—NME1—peripheral nervous system neoplasm	0.00365	0.802	CrCbGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00336	0.0853	CbGpPWpGaD
Tenofovir—AK4—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00318	1	CbGdCrCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00255	0.0647	CbGpPWpGaD
Tenofovir—AK2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00195	0.0495	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00135	0.0343	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00134	0.034	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—peripheral nervous system neoplasm	0.000827	0.021	CbGpPWpGaD
Tenofovir—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000803	0.0204	CbGpPWpGaD
Tenofovir—ABCC10—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000785	0.02	CbGpPWpGaD
Tenofovir—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000682	0.0173	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.000681	0.0173	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—peripheral nervous system neoplasm	0.000617	0.0157	CbGpPWpGaD
Tenofovir—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000521	0.0132	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.000516	0.0131	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.000475	0.0121	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.000471	0.103	CrCbGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—peripheral nervous system neoplasm	0.000465	0.0118	CbGpPWpGaD
Tenofovir—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00044	0.0112	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000378	0.0096	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.000367	0.0806	CrCbGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.00036	0.00914	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—peripheral nervous system neoplasm	0.000308	0.00783	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.000298	0.00756	CbGpPWpGaD
Tenofovir—ABCC4—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000286	0.00727	CbGpPWpGaD
Tenofovir—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000265	0.00673	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000262	0.00666	CbGpPWpGaD
Tenofovir—AK2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000255	0.00649	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000252	0.00641	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000245	0.00622	CbGpPWpGaD
Tenofovir—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000241	0.00613	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000223	0.00567	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000213	0.00542	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—peripheral nervous system neoplasm	0.00021	0.00534	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000204	0.00519	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000201	0.00511	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000199	0.00505	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000196	0.00499	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—peripheral nervous system neoplasm	0.000189	0.0048	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GNS—peripheral nervous system neoplasm	0.000185	0.00469	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000177	0.0045	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NME1—peripheral nervous system neoplasm	0.000177	0.0045	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000176	0.00447	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000175	0.00445	CbGpPWpGaD
Tenofovir—AK2—Metabolism—COX2—peripheral nervous system neoplasm	0.00017	0.00433	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000168	0.00426	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000162	0.00411	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000147	0.00372	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00014	0.00356	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00014	0.00355	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000134	0.00341	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000133	0.00337	CbGpPWpGaD
Tenofovir—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000128	0.00146	CcSEcCtD
Tenofovir—NME2—Metabolism—GNS—peripheral nervous system neoplasm	0.000128	0.00325	CbGpPWpGaD
Tenofovir—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.00146	CcSEcCtD
Tenofovir—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000127	0.00145	CcSEcCtD
Tenofovir—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000127	0.00145	CcSEcCtD
Tenofovir—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000127	0.00145	CcSEcCtD
Tenofovir—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000126	0.00144	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.00144	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00144	CcSEcCtD
Tenofovir—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000125	0.00143	CcSEcCtD
Tenofovir—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000125	0.00143	CcSEcCtD
Tenofovir—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000125	0.00143	CcSEcCtD
Tenofovir—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000125	0.00143	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000125	0.00143	CcSEcCtD
Tenofovir—Back pain—Etoposide—peripheral nervous system neoplasm	0.000124	0.00142	CcSEcCtD
Tenofovir—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000124	0.00141	CcSEcCtD
Tenofovir—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000124	0.00141	CcSEcCtD
Tenofovir—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000123	0.00141	CcSEcCtD
Tenofovir—NME2—Metabolism—NME1—peripheral nervous system neoplasm	0.000123	0.00312	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.0014	CcSEcCtD
Tenofovir—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000122	0.0014	CcSEcCtD
Tenofovir—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.00139	CcSEcCtD
Tenofovir—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000121	0.00138	CcSEcCtD
Tenofovir—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.00138	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00137	CcSEcCtD
Tenofovir—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.00137	CcSEcCtD
Tenofovir—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00012	0.00137	CcSEcCtD
Tenofovir—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000119	0.00136	CcSEcCtD
Tenofovir—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000119	0.00136	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000118	0.00135	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.00135	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000118	0.003	CbGpPWpGaD
Tenofovir—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.00135	CcSEcCtD
Tenofovir—NME2—Metabolism—COX2—peripheral nervous system neoplasm	0.000118	0.003	CbGpPWpGaD
Tenofovir—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000118	0.00135	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000118	0.00135	CcSEcCtD
Tenofovir—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000117	0.00134	CcSEcCtD
Tenofovir—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000117	0.00134	CcSEcCtD
Tenofovir—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000117	0.00134	CcSEcCtD
Tenofovir—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.00133	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00133	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.00132	CcSEcCtD
Tenofovir—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.00132	CcSEcCtD
Tenofovir—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.00131	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.00131	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.00131	CcSEcCtD
Tenofovir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000114	0.0013	CcSEcCtD
Tenofovir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000113	0.00129	CcSEcCtD
Tenofovir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000113	0.00129	CcSEcCtD
Tenofovir—Rash—Topotecan—peripheral nervous system neoplasm	0.000113	0.00129	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000113	0.00286	CbGpPWpGaD
Tenofovir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000112	0.00129	CcSEcCtD
Tenofovir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000112	0.00129	CcSEcCtD
Tenofovir—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Headache—Topotecan—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—AK2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000112	0.00284	CbGpPWpGaD
Tenofovir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.00128	CcSEcCtD
Tenofovir—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000112	0.00127	CcSEcCtD
Tenofovir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000111	0.00127	CcSEcCtD
Tenofovir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00127	CcSEcCtD
Tenofovir—Headache—Tretinoin—peripheral nervous system neoplasm	0.000111	0.00127	CcSEcCtD
Tenofovir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000111	0.00127	CcSEcCtD
Tenofovir—Pain—Vincristine—peripheral nervous system neoplasm	0.000111	0.00126	CcSEcCtD
Tenofovir—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00126	CcSEcCtD
Tenofovir—Rash—Melphalan—peripheral nervous system neoplasm	0.00011	0.00126	CcSEcCtD
Tenofovir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00011	0.00126	CcSEcCtD
Tenofovir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.00125	CcSEcCtD
Tenofovir—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000109	0.00125	CcSEcCtD
Tenofovir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000109	0.00125	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00124	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000109	0.00124	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00122	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00122	CcSEcCtD
Tenofovir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.00121	CcSEcCtD
Tenofovir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.00121	CcSEcCtD
Tenofovir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000106	0.00121	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000106	0.00121	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000105	0.0012	CcSEcCtD
Tenofovir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000105	0.0012	CcSEcCtD
Tenofovir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000105	0.0012	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000104	0.00119	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00264	CbGpPWpGaD
Tenofovir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000104	0.00119	CcSEcCtD
Tenofovir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000104	0.00119	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00118	CcSEcCtD
Tenofovir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000102	0.00117	CcSEcCtD
Tenofovir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000102	0.00117	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000102	0.0026	CbGpPWpGaD
Tenofovir—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000102	0.00117	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000102	0.00116	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000101	0.00116	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00116	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00115	CcSEcCtD
Tenofovir—Anorexia—Etoposide—peripheral nervous system neoplasm	9.99e-05	0.00114	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	9.99e-05	0.00254	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	9.97e-05	0.00253	CbGpPWpGaD
Tenofovir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9.94e-05	0.00114	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.91e-05	0.00113	CcSEcCtD
Tenofovir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.89e-05	0.00113	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.00113	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	9.87e-05	0.00113	CcSEcCtD
Tenofovir—Pain—Cisplatin—peripheral nervous system neoplasm	9.78e-05	0.00112	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.00111	CcSEcCtD
Tenofovir—NME1—Metabolism—GNS—peripheral nervous system neoplasm	9.7e-05	0.00246	CbGpPWpGaD
Tenofovir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.63e-05	0.0011	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.0011	CcSEcCtD
Tenofovir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.53e-05	0.00109	CcSEcCtD
Tenofovir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.5e-05	0.00109	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	9.48e-05	0.00241	CbGpPWpGaD
Tenofovir—AK2—Metabolism—BCHE—peripheral nervous system neoplasm	9.45e-05	0.0024	CbGpPWpGaD
Tenofovir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.00107	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.00107	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.00107	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.00106	CcSEcCtD
Tenofovir—Asthenia—Vincristine—peripheral nervous system neoplasm	9.28e-05	0.00106	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.00106	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.00105	CcSEcCtD
Tenofovir—Infestation—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.00105	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.21e-05	0.00105	CcSEcCtD
Tenofovir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.18e-05	0.00105	CcSEcCtD
Tenofovir—Rash—Dactinomycin—peripheral nervous system neoplasm	9.13e-05	0.00104	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.11e-05	0.00104	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.06e-05	0.0023	CbGpPWpGaD
Tenofovir—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.00103	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.05e-05	0.00103	CcSEcCtD
Tenofovir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.04e-05	0.00103	CcSEcCtD
Tenofovir—Fatigue—Etoposide—peripheral nervous system neoplasm	9.03e-05	0.00103	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.00103	CcSEcCtD
Tenofovir—AK2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.02e-05	0.00229	CbGpPWpGaD
Tenofovir—Pain—Etoposide—peripheral nervous system neoplasm	8.96e-05	0.00102	CcSEcCtD
Tenofovir—NME1—Metabolism—COX2—peripheral nervous system neoplasm	8.95e-05	0.00227	CbGpPWpGaD
Tenofovir—AK2—Metabolism—TH—peripheral nervous system neoplasm	8.89e-05	0.00226	CbGpPWpGaD
Tenofovir—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.00102	CcSEcCtD
Tenofovir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.88e-05	0.00101	CcSEcCtD
Tenofovir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.85e-05	0.00101	CcSEcCtD
Tenofovir—Sweating—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.00101	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.001	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000995	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000988	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000987	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000985	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.6e-05	0.000983	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000979	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000979	CcSEcCtD
Tenofovir—Dizziness—Vincristine—peripheral nervous system neoplasm	8.55e-05	0.000978	CcSEcCtD
Tenofovir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000975	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000974	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000974	CcSEcCtD
Tenofovir—Rash—Alitretinoin—peripheral nervous system neoplasm	8.46e-05	0.000967	CcSEcCtD
Tenofovir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.46e-05	0.000966	CcSEcCtD
Tenofovir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.43e-05	0.000963	CcSEcCtD
Tenofovir—Headache—Alitretinoin—peripheral nervous system neoplasm	8.41e-05	0.000961	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000957	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.36e-05	0.00212	CbGpPWpGaD
Tenofovir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000955	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000947	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000947	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000945	CcSEcCtD
Tenofovir—Vomiting—Vincristine—peripheral nervous system neoplasm	8.22e-05	0.00094	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.21e-05	0.00209	CbGpPWpGaD
Tenofovir—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.21e-05	0.000938	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000934	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000933	CcSEcCtD
Tenofovir—Rash—Vincristine—peripheral nervous system neoplasm	8.16e-05	0.000932	CcSEcCtD
Tenofovir—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.15e-05	0.000931	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000929	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000928	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000926	CcSEcCtD
Tenofovir—Headache—Vincristine—peripheral nervous system neoplasm	8.1e-05	0.000926	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000921	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000914	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.98e-05	0.00203	CbGpPWpGaD
Tenofovir—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.97e-05	0.000911	CcSEcCtD
Tenofovir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.83e-05	0.000894	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	7.81e-05	0.00198	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.77e-05	0.00197	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ENO2—peripheral nervous system neoplasm	7.75e-05	0.00197	CbGpPWpGaD
Tenofovir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.000882	CcSEcCtD
Tenofovir—Nausea—Vincristine—peripheral nervous system neoplasm	7.68e-05	0.000878	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000874	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	7.64e-05	0.00194	CbGpPWpGaD
Tenofovir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000863	CcSEcCtD
Tenofovir—Asthenia—Etoposide—peripheral nervous system neoplasm	7.52e-05	0.000859	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000859	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000857	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000853	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.46e-05	0.0019	CbGpPWpGaD
Tenofovir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000851	CcSEcCtD
Tenofovir—Pruritus—Etoposide—peripheral nervous system neoplasm	7.41e-05	0.000847	CcSEcCtD
Tenofovir—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.27e-05	0.000831	CcSEcCtD
Tenofovir—AK2—Metabolism—GNAS—peripheral nervous system neoplasm	7.25e-05	0.00184	CbGpPWpGaD
Tenofovir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000828	CcSEcCtD
Tenofovir—Rash—Cisplatin—peripheral nervous system neoplasm	7.21e-05	0.000824	CcSEcCtD
Tenofovir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.21e-05	0.000823	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Tenofovir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.17e-05	0.000819	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.15e-05	0.00182	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.12e-05	0.00181	CbGpPWpGaD
Tenofovir—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.00081	CcSEcCtD
Tenofovir—Back pain—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000796	CcSEcCtD
Tenofovir—Dizziness—Etoposide—peripheral nervous system neoplasm	6.93e-05	0.000792	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.00079	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000788	CcSEcCtD
Tenofovir—Nausea—Cisplatin—peripheral nervous system neoplasm	6.79e-05	0.000776	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000766	CcSEcCtD
Tenofovir—Vomiting—Etoposide—peripheral nervous system neoplasm	6.66e-05	0.000761	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000761	CcSEcCtD
Tenofovir—Rash—Etoposide—peripheral nervous system neoplasm	6.61e-05	0.000755	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.6e-05	0.000754	CcSEcCtD
Tenofovir—Headache—Etoposide—peripheral nervous system neoplasm	6.56e-05	0.00075	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.00075	CcSEcCtD
Tenofovir—NME2—Metabolism—BCHE—peripheral nervous system neoplasm	6.55e-05	0.00166	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.55e-05	0.00166	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	6.5e-05	0.00165	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.48e-05	0.00165	CbGpPWpGaD
Tenofovir—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000736	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	6.42e-05	0.0141	CrCbGaD
Tenofovir—NME2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.25e-05	0.00159	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.23e-05	0.00158	CbGpPWpGaD
Tenofovir—Nausea—Etoposide—peripheral nervous system neoplasm	6.22e-05	0.000711	CcSEcCtD
Tenofovir—NME2—Metabolism—TH—peripheral nervous system neoplasm	6.16e-05	0.00156	CbGpPWpGaD
Tenofovir—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.0007	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.0007	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.0007	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000698	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000695	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.03e-05	0.00153	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ENO2—peripheral nervous system neoplasm	5.88e-05	0.00149	CbGpPWpGaD
Tenofovir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000658	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000652	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000649	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000648	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000648	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000648	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000646	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000643	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.00064	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.53e-05	0.00141	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000612	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000609	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000607	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000603	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.0006	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000598	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000592	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000591	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000584	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.00058	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000579	CcSEcCtD
Tenofovir—NME2—Metabolism—GNAS—peripheral nervous system neoplasm	5.03e-05	0.00128	CbGpPWpGaD
Tenofovir—Pain—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000574	CcSEcCtD
Tenofovir—NME1—Metabolism—BCHE—peripheral nervous system neoplasm	4.96e-05	0.00126	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000566	CcSEcCtD
Tenofovir—NME2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.93e-05	0.00125	CbGpPWpGaD
Tenofovir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000562	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000554	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000549	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000547	CcSEcCtD
Tenofovir—NME1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.74e-05	0.0012	CbGpPWpGaD
Tenofovir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.00054	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000536	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000535	CcSEcCtD
Tenofovir—NME1—Metabolism—TH—peripheral nervous system neoplasm	4.67e-05	0.00119	CbGpPWpGaD
Tenofovir—Pain—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000531	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000531	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000531	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000508	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.34e-05	0.0011	CbGpPWpGaD
Tenofovir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000495	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000491	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000491	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.000482	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000475	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.02e-05	0.00102	CbGpPWpGaD
Tenofovir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000459	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000458	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.95e-05	0.001	CbGpPWpGaD
Tenofovir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000446	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000444	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	3.87e-05	0.000984	CbGpPWpGaD
Tenofovir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000439	CcSEcCtD
Tenofovir—NME1—Metabolism—GNAS—peripheral nervous system neoplasm	3.81e-05	0.000968	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.79e-05	0.000962	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.74e-05	0.00095	CbGpPWpGaD
Tenofovir—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000427	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000425	CcSEcCtD
Tenofovir—Rash—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000423	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000423	CcSEcCtD
Tenofovir—Headache—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.000421	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000411	CcSEcCtD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.57e-05	0.000907	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000894	CbGpPWpGaD
Tenofovir—Nausea—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000399	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000395	CcSEcCtD
Tenofovir—Rash—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000392	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000391	CcSEcCtD
Tenofovir—Headache—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000389	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	3.35e-05	0.000851	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.3e-05	0.000837	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000369	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.19e-05	0.000811	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.18e-05	0.000807	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	3.17e-05	0.000805	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.12e-05	0.000792	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.05e-05	0.000774	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.99e-05	0.000759	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.95e-05	0.00075	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.65e-05	0.000674	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.6e-05	0.000661	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.57e-05	0.000652	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.52e-05	0.00064	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.44e-05	0.000621	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.35e-05	0.000598	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2.32e-05	0.000589	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—peripheral nervous system neoplasm	1.96e-05	0.000497	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000468	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.59e-05	0.000404	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.47e-05	0.000373	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000345	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.32e-05	0.000336	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.15e-05	0.000292	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.12e-05	0.000286	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.1e-05	0.00028	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000273	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.000269	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000261	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	9.5e-06	0.000241	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.96e-06	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.88e-06	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.61e-06	0.000143	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.53e-06	0.00014	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.51e-06	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.43e-06	0.000113	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.22e-06	3.1e-05	CbGpPWpGaD
